单孔剑突下入路与单侧肋间入路胸腔镜胸腺切除术的手术结局比较
本研究比较单孔剑突下入路与单侧肋间入路胸腔镜全胸腺切除术治疗Masaoka-Koga I-II期非肌无力胸腺瘤的安全性和可行性。2018年1月至2022年5月共纳入95例患者(剑突下组37例,肋间组58例),倾向性评分匹配后两组各30例。剑突下组在术中出血量、术后24小时视觉模拟评分、住院期间芬太尼追加总剂量及长期神经病理性疼痛评分方面均优于肋间组。
要点
- 倾向性评分匹配后剑突下组术中出血量少于肋间组(P=0.025)。
- 剑突下组术后24小时视觉模拟评分及住院期间芬太尼追加总剂量均低于肋间组(P=0.004和0.018)。
- 剑突下组长期神经病理性疼痛评分低于肋间组(P=0.005)。
核心结论
- 单孔剑突下入路胸腔镜胸腺切除术较肋间入路显示出更有利的围手术期结局,且似乎即刻术后疼痛轻微并在减少长期神经病理性疼痛方面具有优势。
研究设计与样本
- 回顾性比较研究,纳入2018年1月至2022年5月接受单孔剑突下入路或单侧肋间入路胸腔镜全胸腺切除术的Masaoka-Koga I-II期非肌无力胸腺瘤患者,共95例(剑突下组37例,肋间组58例),采用倾向性评分匹配分析比较围手术期结局及即刻和长期疼痛评估。
主要发现
- 倾向性评分匹配后得到两组各30例匹配良好的队列,两组间人口学特征无显著失衡。
- 与肋间组相比,剑突下组术中出血量较少(P=0.025),中位住院时间P=0.083。
- 剑突下组术后24小时视觉模拟评分低于肋间组,住院期间芬太尼追加输注总剂量低于肋间组(P=0.004和0.018)。
- 剑突下组长期神经病理性疼痛量表评分低于肋间组(P=0.005)。
临床怎么用
- 原文结论未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The purpose of this study was to explore the safety and feasibility of video-assisted thoracic surgery (VATS) total thymectomy via the single-port subxiphoid approach compared with the intercostal approach. METHODS: From January 2018 to May 2022, patients who underwent VATS total thymectomy via the subxiphoid or unilateral intercostal approach and diagnosed with Masaoka-Koga stage I-II, non-myasthenic thymoma were included in this study. Perioperative outcomes, immediate and long-term pain evaluations were compared in a propensity score-matching analysis. RESULTS: In total, 95 patients were included and underwent the subxiphoid approach (n = 37) and the intercostal approach (n = 58). Propensity score yielded 2 well-matched cohorts of 30 patients and there was no significant demographical imbalance between the 2 groups. Compared with the intercostal approach, the subxiphoid group demonstrated favourable perioperative outcomes including the intraoperative blood loss (P = 0.025) and the median duration of hospital stay (P = 0.083). The immediate and long-term pain evaluations revealed that the subxiphoid group reported lower visual analogue scales at postoperative 24 h and lower total doses of fentanyl bolus infusions during hospitalization (P = 0.004 and 0.018, respectively), along with lower long-term neuropathic pain scale scores (P = 0.005) than patients in the intercostal group. CONCLUSIONS: VATS thymectomy via the single-port subxiphoid approach showed favourable perioperative outcomes compared to the intercostal approach. Moreover, the subxiphoid approach seemed both to cause minimal immediate postoperative pain and to have advantages in reducing long-term neuropathic pain compared with the intercostal approach.
引用
- Lee J, Cho S, Yoon SH, et al. Surgical outcomes of thoracoscopic thymectomy via the single-port subxiphoid approach versus the unilateral intercostal approach. Interdiscip Cardiovasc Thorac Surg. 2023. PMID: 37792493. doi:10.1093/icvts/ivad141
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。